Asia
Transoral approach aims to achieve scar-free surgery with minimal dissection
The rate of incidence of infection by Naegleria fowleri in the U.S. is very, very low. But there’s something about picking up an incurable, brain-eating amoeba by swimming in freshwater lakes and rivers that understandably freaks people out.
Wave Life Sciences is working to get its nucleic acid treatment, suvodirsen, for Duchenne muscular dystrophy (DMD) approved. DMD is a rare muscle-wasting disease that affects mostly boys, about 15,000 in the U.S.
After conducting a routine research-and-development review, Pfizer is easing away from preclinical biosimilar development. The bottom line is the company is ending five preclinical programs in its biosimilar area and cutting 150 positions.
Couples can choose the gender of the child based on the UAE rules and regulations
Aslan Pharmaceuticals’ first-line therapy for HER1/HER2 co-expressing cancer tumors failed to meet primary endpoints in a mid-stage trial after 12 weeks of treatment, the company announced Sunday.
In 2010, China launched the “Thousand Talents Plan,” which is aimed at attracting top researchers from across the globe.The government of China is reportedly asking officials to quiet down promotion of the program aimed at recruiting western scientists to work in that country.
Valio’s consumer-packaged infant formulas have received an export permit from the Chinese authorities.
On Tuesday, Takeda Pharmaceutical finally wrapped up its $62 billion acquisition of Shire plc. As the combined companies continue to merge and shape their combined roles, Chief Executive Officer Christophe Weber is already eying potential deals to offset some of the debt the company garnered.
Al Ansari Exchange has donated USD 1 million to Gavi, the Vaccine Alliance to support the Alliance mission to create equal and improved access to new and underused vaccines for children living in the world’s poorest countries.
PRESS RELEASES